
### [NCIT:C5237](http://purl.obolibrary.org/obo/NCIT_C5237)
**Label:** Ovarian Neuroendocrine Neoplasm

**Subclasses:** [NCIT:C40014](http://purl.obolibrary.org/obo/NCIT_C40014) (Ovarian Trabecular Carcinoid Tumor), [NCIT:C40015](http://purl.obolibrary.org/obo/NCIT_C40015) (Ovarian Mucinous Carcinoid Tumor), [NCIT:C5229](http://purl.obolibrary.org/obo/NCIT_C5229) (Ovarian Carcinoid Tumor), [NCIT:C40440](http://purl.obolibrary.org/obo/NCIT_C40440) (Ovarian Small Cell Carcinoma, Pulmonary Type), [NCIT:C5238](http://purl.obolibrary.org/obo/NCIT_C5238) (Ovarian Large Cell Neuroendocrine Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C55817](http://purl.obolibrary.org/obo/NCIT_C55817) (Nuclear Molding) 53.85%
- [NCIT:C54209](http://purl.obolibrary.org/obo/NCIT_C54209) (Peripheral Nuclear Palisading) 53.85%
- Thing 52.93%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 42.75%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) 39.20%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) and (not ([NCIT:C39646](http://purl.obolibrary.org/obo/NCIT_C39646) (Erythroderma))) 39.20%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) and (not ([NCIT:C39640](http://purl.obolibrary.org/obo/NCIT_C39640) (Mucinous Degeneration))) 39.20%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) and (not ([NCIT:C39629](http://purl.obolibrary.org/obo/NCIT_C39629) (CDKN2A Gene Inactivation))) 39.20%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) and (not ([NCIT:C39628](http://purl.obolibrary.org/obo/NCIT_C39628) (Single Cell Exocytosis))) 39.20%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) and (not ([NCIT:C39627](http://purl.obolibrary.org/obo/NCIT_C39627) (Pautrier Microabscess Present))) 39.20%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) and (not ([NCIT:C39626](http://purl.obolibrary.org/obo/NCIT_C39626) (Epidermotropic Lymphocytic Infiltrate))) 39.20%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) and (not ([NCIT:C39625](http://purl.obolibrary.org/obo/NCIT_C39625) (Extracutaneous Dissemination of Disease))) 39.20%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) and (not ([NCIT:C39624](http://purl.obolibrary.org/obo/NCIT_C39624) (Skin Plaque))) 39.20%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) and (not ([NCIT:C39622](http://purl.obolibrary.org/obo/NCIT_C39622) (Scaly Skin Eruption))) 39.20%
- [NCIT:C49015](http://purl.obolibrary.org/obo/NCIT_C49015) (Nuclear Palisading) and (not ([NCIT:C39620](http://purl.obolibrary.org/obo/NCIT_C39620) (Dermatopathic Lymphadenopathy))) 39.20%


